全球局部藥物 CDMO 市場研究報告 - 2023 年至 2030 年產業分析、規模、佔有率、成長、趨勢和預測

全球外用藥物 CDMO 市場的需求預計將從 2022 年的 375.8 億美元增至 2030 年的近 966.9 億美元，2023-2030 年研究期間的CAGR為 12.54%。

外用藥品CDMO是指專門為外用藥品提供合約開發和製造外包服務的公司或組織。 CDMO 代表合約開發和製造組織，這些實體專門透過提供與藥物開發、製造（有時甚至是商業化）相關的服務來支援製藥和生物技術產業。

市場動態：

由於幾個關鍵因素，外用藥物合約開發和製造組織 (CDMO) 市場正在蓬勃發展。藥物開發的複雜性日益增加，特別是外用藥物的配方設計，促使製藥公司利用 CDMO 的專業知識。成本效率是一個重要的促進因素，因為外包給外用藥物 CDMO 無需大量內部投資即可獲得專業服務和基礎設施。對核心能力的關注使製藥公司能夠專注於研究和行銷，同時依靠 CDMO 來開發和製造外用藥物。對外用藥品的需求不斷成長、製劑技術的進步以及監管合規的必要性進一步促進了該市場的成長。製藥業的全球化、靈活性、可擴展性和外包趨勢凸顯了外用藥物 CDMO 在加快藥物開發進度和有效滿足市場需求方面的關鍵作用。隨著製藥公司尋求策略合作夥伴關係以應對不斷變化的形勢，外用藥物 CDMO 成為藥品供應鏈中的重要合作者。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球外用藥物 cdmo 市場的每個細分市場進行了包容性評估。外用藥物 cdmo 產業的成長和趨勢為本研究提供了整體方法。

區域分析：

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲局部藥物 CDMO 市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。外用藥物 CDMO 市場的主要參與者包括 Lubrizol Life Science、Cambrex Corporation、Contract Pharmaceuticals Limited、Bora Pharmaceutical CDMO、Ascendia Pharmaceuticals、Pierre Fabre group、Piramal Pharma Solutions、DPT Laboratories, LTD.、MedPharm Ltd.、PCIgroup、Piramal Pharma Solutions、DPT Laboratories, LTD.、MedPharm Ltd.、PCIgroup Pharma Services。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第 1 章：前言

• 報告說明
  • 客觀的
  • 目標受眾
  • 獨特的銷售主張 (USP) 和產品
• 研究範圍
• 研究方法論
  • 市場研究過程
  • 市場研究方法論

第 2 章：執行摘要

• 市場亮點
• 全球市場概況

第 3 章：外用藥物 CDMO - 產業分析

• 簡介 - 市場動態
• 市場促進因素
• 市場限制
• 機會
• 產業動態
• 波特五力分析
• 市場吸引力分析
  • 市場吸引力分析：按產品類型
  • 按服務類型分類的市場吸引力分析
  • 按最終用途分類的市場吸引力分析
  • 市場吸引力分析：按地區

第 4 章：價值鏈分析

• 價值鏈分析
• 原料分析
  • 原料清單
  • 原料廠商清單
  • 主要原物料價格走勢
• 潛在買家名單
• 行銷管道
  • 直效行銷
  • 間接行銷
  • 行銷通路發展趨勢

第 5 章：全球局部藥物 CDMO 市場分析：依產品類型

• 概述：按產品類型
• 歷史和預測數據
• 分析：依產品類型
• 半固體製劑（霜劑、軟膏劑、凝膠劑、其他）
• 液體製劑藥物
• 固體製劑
• 經皮產品

第 6 章：全球專題藥物 CDMO 市場分析：依服務類型

• 按服務類型概述
• 歷史和預測數據
• 按服務類型分析
• 合約開發
• 合約起草（名詞

第 7 章：全球局部藥物 CDMO 市場分析：依最終用途分類

• 按最終用途分類的概述
• 歷史和預測數據
• 按最終用途分析
• 製藥公司
• 生物製藥公司
• 其他

第 8 章：全球局部藥物 CDMO 市場分析：依地理位置

• 區域展望
• 介紹
• 北美銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 北美按細分市場銷售分析
  • 北美按國家銷售分析
  • 美國銷售分析
  • 加拿大銷售分析
  • 墨西哥銷售分析
• 歐洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 歐洲按細分市場銷售分析
  • 歐洲按國家銷售分析
  • 英國銷售分析
  • 法國銷售分析
  • 德國銷售分析
  • 義大利銷售分析
  • 俄羅斯銷售分析
  • 歐洲其他地區銷售分析
• 亞太地區銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 亞太地區按細分市場銷售分析
  • 亞太地區國家/地區銷售分析
  • 中國銷售分析
  • 印度銷售分析
  • 日本銷售分析
  • 韓國銷售分析
  • 澳洲銷售分析
  • 東南亞銷售分析
  • 亞太地區其他地區銷售分析
• 拉丁美洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 拉丁美洲按細分市場銷售分析
  • 拉丁美洲按國家銷售分析
  • 巴西銷售分析
  • 阿根廷銷售分析
  • 秘魯銷售分析
  • 智利銷售分析
  • 拉丁美洲其他地區銷售分析
• 中東和非洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 中東和非洲按細分市場銷售分析
  • 中東和非洲國家銷售分析
  • 沙烏地阿拉伯銷售分析
  • 阿拉伯聯合大公國銷售分析
  • 以色列銷售分析
  • 南非銷售分析
  • 中東其他地區和非洲銷售分析

第 9 章：局部藥品 CDMO 公司的競爭格局

• 外用藥物Cdmo市場競爭
• 夥伴關係/協作/協議
• 併購
• 新產品發布
• 其他發展

第 10 章：公司簡介

• 公司股份分析
• 市場集中度
• Lubrizol Life Science
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Cambrex Corporation
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Contract Pharmaceuticals Limited
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Bora Pharmaceutical CDMO
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Ascendia Pharmaceuticals
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Pierre Fabre group
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Piramal Pharma Solutions
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• DPT Laboratories LTD.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• MedPharm Ltd.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• PCI Pharma Services
• 公司簡介
• 公司收入
• 產品
• 最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

The global demand for Topical Drugs CDMO Market is presumed to reach the market size of nearly USD 96.69 BN by 2030 from USD 37.58 BN in 2022 with a CAGR of 12.54% under the study period 2023 - 2030.

Topical drugs CDMO refers to companies or organizations that provide Contract Development and Manufacturing Outsourcing services specifically for topical pharmaceutical drugs. CDMO stands for Contract Development and Manufacturing Organization, and these entities specialize in supporting the pharmaceutical and biotechnology industries by offering services related to the development, manufacturing, and sometimes commercialization of drugs.

MARKET DYNAMICS:

The Topical Drugs Contract Development and Manufacturing Organization (CDMO) market is thriving due to several key factors. The increasing complexity of drug development, particularly in the formulation design for topical drugs, propels pharmaceutical companies to leverage the specialized expertise of CDMOs. Cost efficiency is a significant driver, as outsourcing to Topical drugs CDMOs provides access to specialized services and infrastructure without substantial in-house investments. The focus on core competencies allows pharmaceutical companies to concentrate on research and marketing while relying on CDMOs for the development and manufacturing of topical drugs. The rising demand for topical drug products, advancements in formulation technologies, and the imperative of regulatory compliance further contribute to the growth of this market. Globalization, flexibility, scalability, and the trend of outsourcing in the pharmaceutical industry underscore the pivotal role of Topical drugs CDMOs in accelerating drug development timelines and meeting market demands efficiently. As pharmaceutical companies seek strategic partnerships to navigate the evolving landscape, Topical drugs CDMOs emerge as crucial collaborators in the pharmaceutical supply chain.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of topical drugs cdmo. The growth and trends of topical drugs cdmo industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the topical drugs cdmo market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

• Semi-Solid Formulations (Creams, Ointments, Gel, Others)
• Liquid Formulations Drugs
• Solid Formulations
• Transdermal Products

By Service Type

• Contract Development
• Contract Manufacturing

By End-Use

• Pharmaceutical Companies
• Biopharmaceutical Companies
• Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Topical Drugs CDMO market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Topical Drugs CDMO market include Lubrizol Life Science, Cambrex Corporation, Contract Pharmaceuticals Limited, Bora Pharmaceutical CDMO, Ascendia Pharmaceuticals, Pierre Fabre group, Piramal Pharma Solutions, DPT Laboratories, LTD., MedPharm Ltd., PCI Pharma Services. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . TOPICAL DRUGS CDMO - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product Type
  • 3.7.2 Market Attractiveness Analysis By Service Type
  • 3.7.3 Market Attractiveness Analysis By End-use
  • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL TOPICAL DRUGS CDMO MARKET ANALYSIS BY PRODUCT TYPE

• 5.1 Overview by Product Type
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Product Type
• 5.4 Semi-solid Formulations (Creams, Ointments, Gel, Others) Historic and Forecast Sales by Regions
• 5.5 Liquid Formulations Drugs Historic and Forecast Sales by Regions
• 5.6 Solid Formulations Historic and Forecast Sales by Regions
• 5.7 Transdermal Products Historic and Forecast Sales by Regions

6 . GLOBAL TOPICAL DRUGS CDMO MARKET ANALYSIS BY SERVICE TYPE

• 6.1 Overview by Service Type
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Service Type
• 6.4 Contract Development Historic and Forecast Sales by Regions
• 6.5 Contract Manufacturing Historic and Forecast Sales by Regions

7 . GLOBAL TOPICAL DRUGS CDMO MARKET ANALYSIS BY END-USE

• 7.1 Overview by End-use
• 7.2 Historical and Forecast Data
• 7.3 Analysis by End-use
• 7.4 Pharmaceutical Companies Historic and Forecast Sales by Regions
• 7.5 Biopharmaceutical Companies Historic and Forecast Sales by Regions
• 7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL TOPICAL DRUGS CDMO MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2. North America By Segment Sales Analysis
  • 8.3.3. North America By Country Sales Analysis
  • 8.3.4. United State Sales Analysis
  • 8.3.5. Canada Sales Analysis
  • 8.3.6. Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2. Europe by Segment Sales Analysis
  • 8.4.3. Europe by Country Sales Analysis
  • 8.4.4. United Kingdom Sales Analysis
  • 8.4.5. France Sales Analysis
  • 8.4.6. Germany Sales Analysis
  • 8.4.7. Italy Sales Analysis
  • 8.4.8. Russia Sales Analysis
  • 8.4.9. Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2. Asia Pacific by Segment Sales Analysis
  • 8.5.3. Asia Pacific by Country Sales Analysis
  • 8.5.4. China Sales Analysis
  • 8.5.5. India Sales Analysis
  • 8.5.6. Japan Sales Analysis
  • 8.5.7. South Korea Sales Analysis
  • 8.5.8. Australia Sales Analysis
  • 8.5.9. South East Asia Sales Analysis
  • 8.5.10. Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2. Latin America by Segment Sales Analysis
  • 8.6.3. Latin America by Country Sales Analysis
  • 8.6.4. Brazil Sales Analysis
  • 8.6.5. Argentina Sales Analysis
  • 8.6.6. Peru Sales Analysis
  • 8.6.7. Chile Sales Analysis
  • 8.6.8. Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2. Middle East & Africa by Segment Sales Analysis
  • 8.7.3. Middle East & Africa by Country Sales Analysis
  • 8.7.4. Saudi Arabia Sales Analysis
  • 8.7.5. UAE Sales Analysis
  • 8.7.6. Israel Sales Analysis
  • 8.7.7. South Africa Sales Analysis
  • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE TOPICAL DRUGS CDMO COMPANIES

• 9.1. Topical Drugs Cdmo Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10 . COMPANY PROFILES OF TOPICAL DRUGS CDMO INDUSTRY

• 10.1. Company Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Lubrizol Life Science
  • 10.3.1. Company Overview
  • 10.3.2. Company Revenue
  • 10.3.3. Products
  • 10.3.4. Recent Developments
• 10.4. Cambrex Corporation
  • 10.4.1. Company Overview
  • 10.4.2. Company Revenue
  • 10.4.3. Products
  • 10.4.4. Recent Developments
• 10.5. Contract Pharmaceuticals Limited
  • 10.5.1. Company Overview
  • 10.5.2. Company Revenue
  • 10.5.3. Products
  • 10.5.4. Recent Developments
• 10.6. Bora Pharmaceutical CDMO
  • 10.6.1. Company Overview
  • 10.6.2. Company Revenue
  • 10.6.3. Products
  • 10.6.4. Recent Developments
• 10.7. Ascendia Pharmaceuticals
  • 10.7.1. Company Overview
  • 10.7.2. Company Revenue
  • 10.7.3. Products
  • 10.7.4. Recent Developments
• 10.8. Pierre Fabre group
  • 10.8.1. Company Overview
  • 10.8.2. Company Revenue
  • 10.8.3. Products
  • 10.8.4. Recent Developments
• 10.9. Piramal Pharma Solutions
  • 10.9.1. Company Overview
  • 10.9.2. Company Revenue
  • 10.9.3. Products
  • 10.9.4. Recent Developments
• 10.10. DPT Laboratories LTD.
  • 10.10.1. Company Overview
  • 10.10.2. Company Revenue
  • 10.10.3. Products
  • 10.10.4. Recent Developments
• 10.11. MedPharm Ltd.
  • 10.11.1. Company Overview
  • 10.11.2. Company Revenue
  • 10.11.3. Products
  • 10.11.4. Recent Developments
• 10.12. PCI Pharma Services
  • 10.12.1. Company Overview
  • 10.12.2. Company Revenue
  • 10.12.3. Products
  • 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Product Type (USD MN)
• Semi-solid Formulations (Creams, Ointments, Gel, Others) Market Sales by Geography (USD MN)
• Liquid Formulations Drugs Market Sales by Geography (USD MN)
• Solid Formulations Market Sales by Geography (USD MN)
• Transdermal Products Market Sales by Geography (USD MN)
• Analysis Market by Service Type (USD MN)
• Contract Development Market Sales by Geography (USD MN)
• Contract Manufacturing Market Sales by Geography (USD MN)
• Analysis by End-use (USD MN)
• Pharmaceutical Companies Market Sales by Geography (USD MN)
• Biopharmaceutical Companies Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Topical Drugs Cdmo Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Topical Drugs Cdmo Report
• Market Research Process
• Market Research Methodology
• Global Topical Drugs Cdmo Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Product Type
• Market Attractiveness Analysis by Service Type
• Market Attractiveness Analysis by End-use
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Product Type (USD MN)
• Semi-solid Formulations (Creams, Ointments, Gel, Others) Market Sales by Geography (USD MN)
• Liquid Formulations Drugs Market Sales by Geography (USD MN)
• Solid Formulations Market Sales by Geography (USD MN)
• Transdermal Products Market Sales by Geography (USD MN)
• Global Market Analysis by Service Type (USD MN)
• Contract Development Market Sales by Geography (USD MN)
• Contract Manufacturing Market Sales by Geography (USD MN)
• Global Market Analysis by End-use (USD MN)
• Pharmaceutical Companies Market Sales by Geography (USD MN)
• Biopharmaceutical Companies Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.